Indian Amikacin Exporters: Complete Supplier Ranking with Market Share — 327 Manufacturers (2026) — TransData Nexus

Q: Who is the largest amikacin supplier from India?

AVET LIFESCIENCES PRIVATE LIMITED is the largest amikacin exporter from India with a 15.2% market share and export value of $3.2M.

Q: How many amikacin suppliers are there in India?

There are 327 active amikacin exporters in India, collectively shipping $21.1M worth of amikacin across 1,657 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top amikacin suppliers from India?

The top 5 amikacin suppliers from India — AVET LIFESCIENCES PRIVATE LIMITED, LINCOLN PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED, EMCURE PHARMACEUTICALS LIMITED, LYKA LABS LIMITED — together control 47.7% of total amikacin export value from India.

Suresh Sormare

Amikacin

India Pharmaceutical Trade Intelligence

$21.1M327 Suppliers104 CountriesHS 30049099

ExportsIndia → IRAQ23.2%India → UNITED STATES17.5%

ImportsIRAQ → India$16.1K UNITED STATES → India$1.5K

#1 Supplier: AVET LIFESCIENCES

Amikacin Suppliers from India (2026) — 327 Exporters, $21.1M Market | TransData Nexus | TransData Nexus

Who Exports Amikacin from India — 327 Suppliers Behind a $21.1M Market

India's amikacin export market is supplied by 327 active exporters who collectively shipped $21.1M across 1,657 shipments. AVET LIFESCIENCES PRIVATE LIMITED leads with a 15.2% market share, followed by LINCOLN PHARMACEUTICALS LTD and AJANTA PHARMA LIMITED. The top 5 suppliers together control 47.7% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Amikacin Suppliers & Exporters — 327 manufacturers, $21.1M export market, top destinations and formulations — Amikacin supplier data — 327 exporters · $21.1M market · 1,657 shipmentsTransData Nexus · Indian Customs Data

Top Amikacin Exporters from India — Ranked by Export Value

AVET LIFESCIENCES PRIVATE LIMITED is the leading amikacin exporter from India, holding a 15.2% share of the $21.1M market across 1,657 shipments from 327 exporters. The top 5 suppliers — AVET LIFESCIENCES PRIVATE LIMITED, LINCOLN PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED, EMCURE PHARMACEUTICALS LIMITED, LYKA LABS LIMITED — collectively control 47.7% of total export value, indicating a competitive market. Individual shares are: AVET LIFESCIENCES PRIVATE LIMITED (15.2%), LINCOLN PHARMACEUTICALS LTD (12.2%), AJANTA PHARMA LIMITED (7.9%), EMCURE PHARMACEUTICALS LIMITED (7.1%), LYKA LABS LIMITED (5.3%).

Top Amikacin Exporters from India

Ranked by export value · 327 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Amikacin Exporters from India — Ranked by Export Value. 327 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Amikacin — Export Intelligence Video

Visual overview of India's amikacin supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's amikacin pharmaceutical supplier landscape — $21.1M in total trade, 327 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Amikacin exporters

Certification and compliance status for top Amikacin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Emcure Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	FDA-approved with WHO and EU GMP certifications; received FDA warning letter in
Ajanta Pharma Limited	Approved	Yes	Yes	27	FDA-approved with WHO and EU GMP certifications; holds 27 ANDAs; no FDA warning
Avet Lifesciences Private Limited	Approved	Unknown	Unknown	Multiple	FDA-approved; multiple ANDAs; WHO and EU GMP status not found; no FDA warning le
Lincoln Pharmaceuticals Ltd	Not Listed	Yes	Yes	Not Applicable	WHO and EU GMP certified; not listed with FDA; no FDA warning letters.
Lyka Labs Limited	Not Listed	Yes	Yes	Not Applicable	WHO and EU GMP certified; not listed with FDA; no FDA warning letters.
Brawn Laboratories Limited	Not Listed	Yes	Yes	Not Applicable	WHO and EU GMP certified; not listed with FDA; no FDA warning letters.
Scott Edil Pharmacia Limited	Not Listed	Yes	Yes	Not Applicable	WHO and EU GMP certified; not listed with FDA; no FDA warning letters.
Laborate Pharmaceuticals India Ltd	Not Listed	Yes	Yes	Not Applicable	WHO and EU GMP certified; not listed with FDA; no FDA warning letters.
Kwality Pharmaceuticals Limited	Not Listed	Yes	Yes	Not Applicable	WHO and EU GMP certified; not listed with FDA; no FDA warning letters.

TransData Nexus reviewed the regulatory standing of 9 leading Amikacin exporters from India. 3 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Amikacin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts numerous pharmaceutical companies specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), including antibiotics like Amikacin. The establishment of Hyderabad Pharma City aims to further enhance this ecosystem by providing integrated facilities for pharmaceutical manufacturing, research, and development.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region houses several leading pharmaceutical companies that specialize in producing finished dosage forms, including injectables and oral formulations. The presence of a robust infrastructure and a skilled workforce makes this cluster pivotal in the formulation of antibiotics such as Amikacin.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad region serves as a significant export gateway for pharmaceutical products. With its proximity to major ports and well-established logistics networks, this cluster facilitates the efficient export of antibiotics like Amikacin to global markets. The region's pharmaceutical companies benefit from advanced manufacturing facilities and regulatory compliance, ensuring the production of high-quality products for international distribution.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Amikacin exporters from India

July 2024

M&A

Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals launches IPO on NSE and BSE

Emcure Pharmaceuticals Limited, a leading Indian pharmaceutical company, launched its initial public offering (IPO) and listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) in July 2024. - IMPACT: The IPO is expected to provide Emcure with additional capital to expand its operations, potentially enhancing its Amikacin production and export capabilities.

Impact: The IPO is expected to provide Emcure with additional capital to expand its operations, potentially enhancing its Amikacin production and export capabilities.

November 2025

M&A

Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals to acquire remaining stake in Zuventus Healthcare

Emcure Pharmaceuticals announced its decision to purchase the outstanding minority interest in Zuventus Healthcare, its subsidiary, for ₹724.9 crore. This acquisition aims to simplify Emcure's corporate structure and strengthen its position in the domestic pharmaceutical market. - IMPACT: The full acquisition of Zuventus Healthcare may lead to operational synergies, potentially boosting Amikacin production and exports.

Impact: The full acquisition of Zuventus Healthcare may lead to operational synergies, potentially boosting Amikacin production and exports.

Common Questions — Amikacin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which amikacin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, AVET LIFESCIENCES PRIVATE LIMITED leads with 47 recorded shipments worth $3.2M. LINCOLN PHARMACEUTICALS LTD (9 shipments) and AJANTA PHARMA LIMITED (28 shipments) are also established high-volume exporters.

Q How many amikacin manufacturers are there in India?

India has 327 active amikacin exporters with a combined export market of $21.1M across 1,657 shipments to 104 countries. The top 5 suppliers hold 47.7% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for amikacin from India?

Average FOB unit price: $5.67 per unit, ranging from $0.01 to $708.12. Average shipment value: $12.7K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Amikacin

Amikacin

Who Exports Amikacin from India — 327 Suppliers Behind a $21.1M Market

Top Amikacin Exporters from India — Ranked by Export Value

Top Amikacin Exporters from India

Related Analysis

Need Details?

Amikacin — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals launches IPO on NSE and BSE

Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals to acquire remaining stake in Zuventus Healthcare

Common Questions — Amikacin Suppliers from India

Q Which amikacin supplier from India is the most reliable for bulk orders?

Q How many amikacin manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for amikacin from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Eris Lifesciences and Natco Pharma Limited — Eris Lifesciences partners with Natco Pharma to commercialize semaglutide in India

Analysis Methodology